Alnylam Pharmaceuticals competitors
Alnylam Pharmaceuticals's competitors include ANI Pharmaceuticals, Immune Therapeutics, Catalyst Pharmaceuticals and Aerie Pharmaceuticals
Add company...
You can compare up to 12 companies. Please remove a company to add a new one
| Save ComparisonClear all |  Alnylam Pharmaceuticals Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. |  ANI Pharmaceuticals ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A. |  Immune Therapeutics Immune Therapeutics is a specialty pharmaceutical company involved in the manufacturing and distribution of immunotherapies. |  Catalyst Pharmaceuticals Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases. |  Aerie Pharmaceuticals Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. |
Founding Date | Founding Date 2002 | Founding Date 1996 | Founding Date 2012 | Founding Date 2002 | Founding Date 2005 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Cambridge, US HQ Zug, CH Windsor And Maidenhead, GB | Locations Baudette, US HQ Baudette, US | Locations Orlando, US HQ | Locations Coral Gables, US HQ | Locations Irvine, US HQ Dublin, IE Bedminster Township, US Durham, US |
Employees | Employees 514 | Employees 143 | Employees 10 | Employees 18 | Employees 9536% increase |
Valuation ($) | Valuation ($) 10.8 b | Valuation ($) 782.6 m | Valuation ($) 8.4 m | Valuation ($) 354 m | Valuation ($) 2.5 b |
Twitter followers | Twitter followers 8 k | Twitter followers N/A | Twitter followers 94 | Twitter followers 436 | Twitter followers N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $176.8m (FY, 2017) | Revenue (est.) $3.5k (FY, 2016) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($490.9m) (FY, 2017) | Net income N/A | Net income ($19.8m) (FY, 2016) | Net income ($18.4m) (FY, 2017) | Net income ($145.1m) (FY, 2017) |
Funding | |||||
Total funding raised | Total funding raised $ 710m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 388.6m |
For sources of this data, please see the company profileDownload Excel
View company profiles
ANI Pharmaceuticals
HQ
Baudette, US
Employees
143
ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A.
View companyImmune Therapeutics
HQ
Orlando, US
Employees
10
Immune Therapeutics is a specialty pharmaceutical company involved in the manufacturing and distribution of immunotherapies.
View companyCatalyst Pharmaceuticals
HQ
Coral Gables, US
Employees
18
Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases.
View companyAerie Pharmaceuticals
HQ
Irvine, US
Employees
95↑ 36% increase
Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.
View company